Pancreatic Cancer Research

ResearcherTianjin University of Traditional Chinese MedicineActive in the last 2 years

Haipeng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7856-4488; OpenAlex author ID A5100363265. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. The prognostic role of lymphocyte-to-monocyte ratio in patients with resectable pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.7717/peerj.17585↗
  2. Bibliometric Analysis of Hotspots and Frontiers of Immunotherapy in Pancreatic Cancer. Co-author DOI 10.3390/healthcare11030304↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiong Xu · 1 shared paper, 2023 · strength 0.22
  2. Hui Wang · 1 shared paper, 2023 · strength 0.22
  3. Jingyu Min · 1 shared paper, 2024 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.